TPTX » Topics » If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

This excerpt taken from the TPTX DEF 14A filed Jun 19, 2009.

If our product candidates do not achieve market acceptance among physicians, patients, health care payers and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

 

   

acceptable evidence of safety and efficacy;

 

   

relative convenience and ease of administration;

 

   

the prevalence and severity of any adverse side effects;

 

   

availability of alternative treatments;

 

   

pricing and cost effectiveness;

 

   

effectiveness of sales and marketing strategies; and

 

   

ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

This excerpt taken from the TPTX 10-Q filed May 1, 2009.

If our product candidates do not achieve market acceptance among physicians, patients, health care payers and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

 

   

acceptable evidence of safety and efficacy;

 

   

relative convenience and ease of administration;

 

   

the prevalence and severity of any adverse side effects;

 

   

availability of alternative treatments;

 

   

pricing and cost effectiveness;

 

   

effectiveness of sales and marketing strategies; and

 

   

ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

These excerpts taken from the TPTX 10-K filed Mar 27, 2009.

If our product candidates do not achieve market acceptance among physicians, patients, health care payers and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

 

   

acceptable evidence of safety and efficacy;

 

   

relative convenience and ease of administration;

 

   

the prevalence and severity of any adverse side effects;

 

   

availability of alternative treatments;

 

   

pricing and cost effectiveness;

 

   

effectiveness of sales and marketing strategies; and

 

   

ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

If our product candidates do not achieve market
acceptance among physicians, patients, health care payers and the medical community, they will not be commercially successful and our business will be adversely affected.

STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%">The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will
depend on a number of factors, including:

 







  

acceptable evidence of safety and efficacy;

 







  

relative convenience and ease of administration;

 







  

the prevalence and severity of any adverse side effects;

 







  

availability of alternative treatments;

 







  

pricing and cost effectiveness;

 







  

effectiveness of sales and marketing strategies; and

 







  

ability to obtain sufficient third-party coverage or reimbursement.

FACE="Times New Roman" SIZE="2">If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

STYLE="margin-top:18px;margin-bottom:0px">If we fail to attract and keep key management and scientific personnel, we may be unable to develop or commercialize our product candidates successfully.

Our success depends on our continued ability to attract, retain and motivate highly qualified management and scientific personnel. The loss
of the services of any principal member of our senior management team could

 


23







Table of Contents



delay or prevent the commercialization of our product candidates. We employ these individuals on an at-will basis and their employment can be terminated by
us or them at any time, for any reason and with or without notice, subject to the terms contained in their respective employment agreements and offer letters.

FACE="Times New Roman" SIZE="2">Competition for qualified personnel in the drug development industry is intense. We may not be able to attract and retain quality personnel on acceptable terms given the competition for such personnel among
biotechnology, pharmaceutical and other companies.

This excerpt taken from the TPTX 10-Q filed Nov 12, 2008.

If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

 

   

acceptable evidence of safety and efficacy;

 

   

relative convenience and ease of administration;

 

   

the prevalence and severity of any adverse side effects;

 

20


Table of Contents
   

availability of alternative treatments;

 

   

pricing and cost effectiveness;

 

   

effectiveness of sales and marketing strategies; and

 

   

ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

This excerpt taken from the TPTX 10-Q filed Aug 12, 2008.

If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

 

   

acceptable evidence of safety and efficacy;

 

   

relative convenience and ease of administration;

 

20


Table of Contents
   

the prevalence and severity of any adverse side effects;

 

   

availability of alternative treatments;

 

   

pricing and cost effectiveness;

 

   

effectiveness of sales and marketing strategies; and

 

   

ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

This excerpt taken from the TPTX 10-Q filed May 13, 2008.
If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

 

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

 

17



 

·      acceptable evidence of safety and efficacy;

 

·      relative convenience and ease of administration;

 

·      the prevalence and severity of any adverse side effects;

 

·      availability of alternative treatments;

 

·      pricing and cost effectiveness;

 

·      effectiveness of sales and marketing strategies; and

 

·      ability to obtain sufficient third-party coverage or reimbursement.

 

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

 

These excerpts taken from the TPTX 10-K filed Mar 31, 2008.

If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

        The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

    acceptable evidence of safety and efficacy;

    relative convenience and ease of administration;

    the prevalence and severity of any adverse side effects;

    availability of alternative treatments;

    pricing and cost effectiveness;

    effectiveness of sales and marketing strategies; and

    ability to obtain sufficient third-party coverage or reimbursement.

        If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

25


If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be
commercially successful and our business will be adversely affected.




        The
degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors,
including:





    acceptable
    evidence of safety and efficacy;


    relative
    convenience and ease of administration;


    the
    prevalence and severity of any adverse side effects;


    availability
    of alternative treatments;


    pricing
    and cost effectiveness;


    effectiveness
    of sales and marketing strategies; and


    ability
    to obtain sufficient third-party coverage or reimbursement.



        If
we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.



25









This excerpt taken from the TPTX 10-Q filed Nov 14, 2007.
If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

      acceptable evidence of safety and efficacy;

      relative convenience and ease of administration;

      the prevalence and severity of any adverse side effects;

      availability of alternative treatments;

      pricing and cost effectiveness;

      effectiveness of sales and marketing strategies; and

      ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

 

23



 

This excerpt taken from the TPTX 10-Q filed Aug 14, 2007.
If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

·      acceptable evidence of safety and efficacy;

·      relative convenience and ease of administration;

·      the prevalence and severity of any adverse side effects;

·      availability of alternative treatments;

·      pricing and cost effectiveness;

·      effectiveness of sales and marketing strategies; and

·      ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

This excerpt taken from the TPTX 10-Q filed May 14, 2007.
If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

·         acceptable evidence of safety and efficacy;

·         relative convenience and ease of administration:

·         the prevalence and severity of any adverse side effects;

·         availability of alternative treatments;

·         pricing and cost effectiveness;

·         effectiveness of sales and marketing strategies; and

·         ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

This excerpt taken from the TPTX 10-K filed Mar 29, 2007.

If our product candidates do not achieve market acceptance among physicians, patients, health care payors and the medical community, they will not be commercially successful and our business will be adversely affected.

The degree of market acceptance of any of our approved product candidates among physicians, patients, health care payors and the medical community will depend on a number of factors, including:

·       acceptable evidence of safety and efficacy;

·       relative convenience and ease of administration:

·       the prevalence and severity of any adverse side effects;

·       availability of alternative treatments;

·       pricing and cost effectiveness;

·       effectiveness of sales and marketing strategies; and

·       ability to obtain sufficient third-party coverage or reimbursement.

If we are unable to achieve market acceptance for our product candidates, then such product candidates will not be commercially successful and our business will be adversely affected.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki